T5. Before we deploy them we should prove they are relevant to our patients, develop efficient macros/separate reports as needed, and provide extensive referring clinician education. Ideally patient, too. Mammo letters are not a bad notification model. #RadAIchat

Really enjoyed the discussion! Thanks to Abhinav Suri, MPH, Hesham Elhalawani Charles Kahn, MD and RadiologyAI for invite, for organizing and insightful questions on AI-opportunistic (ambient) screening. #RadAIChat

Join us on Wednesday 11 EST- what's new in🫁lung ☢️#radonc ⚡️webinar details below! #LCSM @iaslc Fiona McDonald Houda Bahig, MD PhD Pranshu Mohindra Shankar Siva Corinne Faivre-Finn 💙 Dr. David Palma Drew Moghanaki 🐕 Matthias Guckenberger Joe Y Chang

🚨#Cardioonc #lungcancer study highlight! tinyurl.com/3ezfpwtn Led by Bonnie Ky Paco E. Bravo, MD Cliff Robinson Ray Mak, MD Marcelo Di Carli Joshua Mitchell Nitin Ohri @SalmaJabbour1Michael Soike Manuj Agarwal Steve Feigenberg & William Levin Penn Medicine - Abramson Cancer Center #LungCancerAwarenessMonth

I had a great time discussing our research developing #NLP methods to actively support patients undergoing radiotherapy and other cancer treatment AtlanticLIVE #PeopleVCancer @massgenbrigham Brigham and Women’s Research

🗞️ Our latest work out today in Nature Communications 🌟 Led by star research fellow Anna Zapaishchykova 🧠 Automated temporalis muscle quantification and growth charts for children through adulthood rdcu.be/dqFGu 🧵 1/

#LLMs might help burnout by drafting responding to patient portal messages in #EHRs. But is this a low-risk efficiency aid, or do #LLMs impact clinical judgement in more meaningful ways? We investigated this in our new study out in The Lancet Digital Health: thelancet.com/journals/landi… 1/

Read “Body Composition in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy” now in JAMA Oncology at 10.1001/jamaoncol.2024.1120 Tafadzwa L. Chaunzwa Hugo Aerts Jack Qian, MD Ray Mak, MD et al

Katelyn Atkins, MD, PHD & Ray Mak, MD take cardiac substructure-specific endpoint analysis to new heights in radiotherapy cardiotoxicity research! Alan McWilliam & myself provide some thoughts on the implications of this awesome paper in a linked editorial: jacc.org/doi/10.1016/j.…